| Title | Therapeutic Advances in Chronic Disease |
| Abbreviation | Ther. Adv. Chronic Dis. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q1) |
| h-index | 44 |
| Overall Rank/Ranking | 4388 |
| SCImago Journal Rank (SJR) | 0.975 |
| Impact Score | 3.37 |
| Publisher | SAGE Publications Inc. |
| Country | United States |
| ISSN | 20406231, 20406223 |
| Best Quartile | Q1 |
| Coverage History | 2010-2022 |
Therapeutic Advances in Chronic Disease is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q1). It is published by SAGE Publications Inc.. The overall rank of Therapeutic Advances in Chronic Disease is 4388. According to SCImago Journal Rank (SJR), this journal is ranked 0.975. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 44. The best quartile for this journal is Q1.
The ISSN of Therapeutic Advances in Chronic Disease journal is 20406231, 20406223. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Chronic Disease is cited by a total of 997 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Therapeutic Advances in Chronic Disease is 3.37, which is computed in 2023 as per its definition. Therapeutic Advances in Chronic Disease IF is decreased by a factor of 1.17 and approximate percentage change is -25.77% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Therapeutic Advances in Chronic Disease is 3.37. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.37 |
| 2021 | 4.54 |
| 2020 | 4.65 |
| 2019 | 4.66 |
| 2018 | 4.60 |
| 2017 | 5.29 |
| 2016 | 4.71 |
| 2015 | 4.40 |
| 2014 | 3.56 |
Therapeutic Advances in Chronic Disease has an h-index of 44. It means 44 articles of this journal have more than 44 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Therapeutic Advances in Chronic Disease is 20406231, 20406223. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Therapeutic Advances in Chronic Disease is 4388. According to SCImago Journal Rank (SJR), this journal is ranked 0.975. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.975 |
| 2021 | 1.019 |
| 2020 | 1.027 |
| 2019 | 1.384 |
| 2018 | 1.516 |
| 2017 | 1.895 |
| 2016 | 1.266 |
| 2015 | 0.922 |
| 2014 | 0.638 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 4388 |
| 2021 | 3981 |
| 2020 | 4223 |
| 2019 | 2569 |
| 2018 | 2207 |
| 2017 | 1515 |
| 2016 | 3082 |
| 2015 | 4958 |
| 2014 | 7308 |
Therapeutic Advances in Chronic Disease is published by SAGE Publications Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2010-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Therapeutic Advances in Chronic Disease is Ther. Adv. Chronic Dis.. This abbreviation ('Ther. Adv. Chronic Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Therapeutic Advances in Chronic Disease latest impact IF is 3.37. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.29 (2017) and 3.37 (2022), respectively, in the last 9 years. Moreover, its average IS is 4.42 in the previous 9 years.
The Therapeutic Advances in Chronic Disease has an SJR (SCImago Journal Rank) of 0.975, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.895 in 2017 and the lowest being 0.638 in 2014. Furthermore, the average SJR of the Therapeutic Advances in Chronic Disease over the previous 9-year period stands at 4.42.
The latest h-index of the Therapeutic Advances in Chronic Disease is 44.
The Therapeutic Advances in Chronic Disease is published by the SAGE Publications Inc., with its country of publication being the United States.
The Therapeutic Advances in Chronic Disease is currently ranked 4388 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1515 in 2017 and its lowest position of 7308 in 2014.
The standard ISO4 abbreviation for the Therapeutic Advances in Chronic Disease is Ther. Adv. Chronic Dis..
Therapeutic Advances in Chronic Disease is classified as a journal that the SAGE Publications Inc. publishes.
The Therapeutic Advances in Chronic Disease encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Therapeutic Advances in Chronic Disease is assigned the following International Standard Serial Numbers (ISSN): 20406231, 20406223.
The best quartile for the Therapeutic Advances in Chronic Disease is Q1 (2022).
The Therapeutic Advances in Chronic Disease coverage history can be summarized as follows: 2010-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Analysis in Theory and Applications | journal | 19346 | Springer Netherlands | 11 | 0.00 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Criminal Justice Review | journal | 8738 | SAGE Publications Inc. | 41 | 1.30 |
| International Journal of Applied Linguistics | journal | 7321 | Wiley-Blackwell Publishing Ltd | 51 | 2.00 |
| Modern Language Journal | journal | 918 | Wiley-Blackwell | 103 | 3.89 |
| Metascience | journal | 13645 | Springer Nature | 3 | 0.13 |
| Physica Status Solidi - Rapid Research Letters | journal | 6699 | Wiley-VCH Verlag | 76 | 2.77 |
| American Journal of Immunology (discontinued) | journal | 19764 | Science Publications | 12 | 1.56 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.37 |
| 2021 | 4.54 |
| 2020 | 4.65 |
| 2019 | 4.66 |
| 2018 | 4.60 |
| 2017 | 5.29 |
| 2016 | 4.71 |
| 2015 | 4.40 |
| 2014 | 3.56 |
